Literature DB >> 4352107

Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragm.

C C Chang, T F Chen, S T Chuang.   

Abstract

1. Rats were treated twice daily for 7 days with neostigmine and the diaphragm was isolated for study of its acetylcholine content, release upon nerve stimulation and the number of receptors in the end-plate.2. While the content of total acetylcholine was unchanged, the release of acetylcholine on stimulation with trains of 500 pulses at 100 Hz every 20 sec was reduced by about 50%. Five days after the end of neostigmine treatment the release of acetylcholine recovered to normal.3. The total number of acetylcholine receptors in the end-plate as measured from the binding of N, O-di[(3)H]acetyl alpha-bungarotoxin was reduced from 2.1 x 10(7) to 1.2 x 10(7) per end-plate.4. The above-mentioned changes are not due to acute pharmacological effects of neostigmine, nor to an immediate effect of cholinesterase inhibition but presumably due to chronic accumulation of acetylcholine at the neuromuscular junction.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4352107      PMCID: PMC1350618          DOI: 10.1113/jphysiol.1973.sp010207

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  16 in total

1.  A study of supersensitivity in denervated mammalian skeletal muscle.

Authors:  J AXELSSON; S THESLEFF
Journal:  J Physiol       Date:  1959-06-23       Impact factor: 5.182

2.  ISOLATION OF NEUROTOXINS FROM THE VENOM OF BUNGARUS MULTICINCTUS AND THEIR MODES OF NEUROMUSCULAR BLOCKING ACTION.

Authors:  C C CHANG; C Y LEE
Journal:  Arch Int Pharmacodyn Ther       Date:  1963-07-01

3.  The acetylcholine sensitivity of frog muscle fibres after complete or partial devervation.

Authors:  R MILEDI
Journal:  J Physiol       Date:  1960-04       Impact factor: 5.182

4.  Motor units in the rat diaphragm.

Authors:  K KRNJEVIC; R MILEDI
Journal:  J Physiol       Date:  1958-03-11       Impact factor: 5.182

5.  Acetylcholine receptors in muscle fibres.

Authors:  R Miledi; L T Potter
Journal:  Nature       Date:  1971-10-29       Impact factor: 49.962

Review 6.  "Trophic" influences of nerve on muscle.

Authors:  L Guth
Journal:  Physiol Rev       Date:  1968-10       Impact factor: 37.312

7.  Tolerance to neostigmine.

Authors:  G A Buckley; C E Heading
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

8.  Subsensitivity of the rat ileum to cholinergic drugs.

Authors:  J J McPhillips
Journal:  J Pharmacol Exp Ther       Date:  1969-04       Impact factor: 4.030

9.  N,O-di and N,N,O-tri ( 3 H) acetyl -bungarotoxins as specific labelling agents of cholinergic receptors.

Authors:  C C Chang; T F Chen; S T Chuang
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

10.  Acetylcholine receptors: number and distribution at neuromuscular junctions in rat diaphragm.

Authors:  D M Fambrough; H C Hartzell
Journal:  Science       Date:  1972-04-14       Impact factor: 47.728

View more
  12 in total

Review 1.  Immunohistochemistry of cholinergic receptors.

Authors:  H Schröder
Journal:  Anat Embryol (Berl)       Date:  1992-10

2.  Effects of chronic treatment with various neuromuscular blocking agents on the number and distribution of acetylcholine receptors in the rat diaphragm.

Authors:  C C Chang; S T Chuang; M C Huang
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

3.  The effect of chronic neostigmine treatment on channel properties at the rat skeletal neuromuscular junction.

Authors:  M Gwilt; D Wray
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

4.  On the interaction of drugs with the cholinergic nervous system. VI. Tolerance to physostigmine in mice.

Authors:  S Maayani; Y Egozi; I Pinchasi; M Sokolovsky
Journal:  Psychopharmacology (Berl)       Date:  1977-11-24       Impact factor: 4.530

Review 5.  Immunopathology of acetylcholine receptors in myasthenia gravis.

Authors:  M E Seybold; J M Lindstrom
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Therapeutic properties.of haemodialysis and blood exchange transfusion in organophosphate poisoning.

Authors:  S Okonek; G Boelcke; H Hollmann
Journal:  Eur J Intensive Care Med       Date:  1976

7.  Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody.

Authors:  Marco Morsch; Stephen W Reddel; Nazanin Ghazanfari; Klaus V Toyka; William D Phillips
Journal:  J Physiol       Date:  2013-02-25       Impact factor: 5.182

8.  Development and disappearance of subsensitivity to pilocarpine following a single administration of the irreversible anticholinesterase angent, DFP.

Authors:  D H Overstreet; S C Helps; A M Prescott; G D Schiller
Journal:  Psychopharmacology (Berl)       Date:  1977-05-09       Impact factor: 4.530

9.  Salbutamol and ephedrine in the treatment of severe AChR deficiency syndromes.

Authors:  Pedro M Rodríguez Cruz; Jacqueline Palace; Hayley Ramjattan; Sandeep Jayawant; Stephanie A Robb; David Beeson
Journal:  Neurology       Date:  2015-09-22       Impact factor: 9.910

10.  Influence of neostigmine treatment on embryonic development of acetylcholine receptors and neuromuscular junctions.

Authors:  G S Sohal; W R Boydston
Journal:  J Cell Biol       Date:  1982-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.